background

About Us

BMED, established in 2017, has taken its place in the Turkish pharmaceutical industry with its products used in the treatment of rare diseases.

BMED, established in 2017, has taken its place in the Turkish pharmaceutical industry with its products used in the treatment of rare diseases.

BMED, established in 2017, has taken its place in the Turkish pharmaceutical industry with rare disease treatments.

The target of BMED, which has partnerships with the world's leading pharmaceutical companies, is to ensure that rare treatments are delivered to patients easily, safely and quickly, within the framework of ethical and scientific values ​​and with an understanding of quality products.

It brings together the products used in the treatment of rare diseases in many branches, especially in Endocrinology, Allergy, Oncology, Hematology, Ophthalmology and Neurology, and works devotedly in the treatment of rare diseases.

Headquartered in Ankara, BMED also has offices in Istanbul. BMED carries out the sales and marketing of the products in its portfolio to a wide geography in Turkey with its field staff.

In this direction, BMED, with 12 different partners from 10 different countries, enables patients to reach the treatments needed in Turkey. BMED constantly enriches its portfolio and continues on its way in line with its target of becoming the largest pharmaceutical company in the treatment of rare diseases in Turkey.",

background

BMED Pharmaceuticals For The Treatment Of Rare Diseases.

BMED Pharmaceuticals aims to provide effective and reliable treatment to patients with the drugs approved by the Ministry of Health, which it has provided in many fields. Please click to review our products or Rare Treatments in detail.

Allergy & Immunology

Hematology

Oncology

Cardiology

In case of any side effects, please call our side effect support line. You can fill out our contact form for detailed information about our products. Contact Information